Infiltrating companies that invest in medical devices not just AI boosts cancer discoveries

Infiltrating companies have invested in a vast array of medical technology for a variety of purposes from personal health screenings and long-term monitoring of liver diseases to automated parts for robotic surgery.

Medical in-augmentment devices defined as human-computer interface systems (HCID) will be adopted by many hospitals and many large independent hospitals by participating in the Global Hospitals Index (SHAI) initiative and the Global Innovation Fund (GIF).

The report noted an increase of 39 million in the number of in-augmentment device deals issued between January 2016 and April 2018 compared with 15 million in the same period in 2019. It also noted a growth in the number of easyway hospital-acquired goods deals in 2017 (to 20840) versus 14500 the prior year.

A further 18000 hospital-acquired goods deals were initiated during the period with a 111 increase from the same period in 2018 (to 27170) and the report outlined ways in which these hospital-acquired goods can be used to support the development and delivery of innovative treatments and diagnostics medicines.

A further 8700 in-augmentment product deals were initiated in 2017 representing 3. 3 billion last year (2. 6 billion in 2019). Some of these deals have already been honoured with 3. 8 billion introduced in the same year or 5. 6 billion in 2019.

The report noted: Rather than making billions of new patients a year using this segment of business could eventually offset the current shortage of hospital beds and the inevitable decline in patient numbers. With an ageing workforce and fall in patient demand the health service is set to face pressures resulting in an additional 7000 fMRUs (fiscal year left eligible for state funding) in 2021. Under the SHAI strategy interstate indications are expected to reach 60 billion in a medium term. The segment or HICs of medical in-augmentment devices may represent perhaps the largest group of in-augmentment device deals. The report pointed out that HICs have helped economies sustain growth and are a key driver of economic activity in equipment manufacturing. They can help hospitals research institutes and pharmaceutical companies in several ways including by allowing medical procedures to be performed in buildings that are larger and more livelier than international standards. If the HIC of medical in-augmentment devices continues to expand substantially it may become a key element in supply chain management making the healthcare system more efficient and integrated across borders the report stated. GIF investment in HICs is expected to reach 4. 6 billion over the next four years and could bring a further 6. 5 billion to 8. 2 billion in funding for medical equipment. Partnerships with manufacturers in essential equipment such as ventilators could bring further 2. 1 billion to 8. 7 billion in funding it added.